Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin

This study has been withdrawn prior to enrollment.
(Business purposes.)
Sponsor:
Information provided by (Responsible Party):
CPEX Pharmaceuticals Inc.
ClinicalTrials.gov Identifier:
NCT00850161
First received: February 23, 2009
Last updated: February 12, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: September 2010
  Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)